BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11463563)

  • 1. Small cell lung cancer I--III A: cytoreductive chemotherapy followed by resection with continuation of chemotherapy.
    Lewiński T; Zuławski M; Turski C; Pietraszek A
    Eur J Cardiothorac Surg; 2001 Aug; 20(2):391-8. PubMed ID: 11463563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term results of surgery and chemotherapy in small cell lung cancer.
    Rea F; Callegaro D; Favaretto A; Loy M; Paccagnella A; Fantoni U; Festi G; Sartori F
    Eur J Cardiothorac Surg; 1998 Oct; 14(4):398-402. PubMed ID: 9845145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postchemotherapy resection of residual tumor in limited stage small cell lung cancer.
    Johnson DH; Einhorn LH; Mandelbaum I; Williams SD; Greco FA
    Chest; 1987 Aug; 92(2):241-6. PubMed ID: 3038475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there ever a role for salvage operations in limited small-cell lung cancer?
    Shepherd FA; Ginsberg R; Patterson GA; Feld R; Goss PE; Pearson FG; Todd TJ; Winton T; Rubinger M; Johansen E
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):196-200. PubMed ID: 1846927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
    Badzio A; Kurowski K; Karnicka-Mlodkowska H; Jassem J
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):183-8. PubMed ID: 15200999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience.
    Shepherd FA; Ginsberg RJ; Feld R; Evans WK; Johansen E
    J Thorac Cardiovasc Surg; 1991 Mar; 101(3):385-93. PubMed ID: 1847981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery in the management of small cell lung cancer.
    Lucchi M; Mussi A; Chella A; Janni A; Ribechini A; Menconi GF; Angeletti CA
    Eur J Cardiothorac Surg; 1997 Nov; 12(5):689-93. PubMed ID: 9458136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study.
    Shepherd FA; Ginsberg RJ; Patterson GA; Evans WK; Feld R
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):177-86. PubMed ID: 2536868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935.
    Jaklitsch MT; Herndon JE; DeCamp MM; Richards WG; Kumar P; Krasna MJ; Green MR; Sugarbaker DJ
    J Surg Oncol; 2006 Dec; 94(7):599-606. PubMed ID: 17039491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
    Rice TW; Adelstein DJ; Koka A; Tefft M; Kirby TJ; Van Kirk MA; Taylor ME; Olencki TE; Peereboom D; Budd GT
    Ann Thorac Surg; 1995 Sep; 60(3):586-91; discussion 591-2. PubMed ID: 7677484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
    Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
    J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy.
    Isaka M; Kojima H; Takahashi S; Omae K; Ohde Y
    Lung Cancer; 2018 Jan; 115():28-33. PubMed ID: 29290258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy following surgical resection for small-cell carcinoma of the lung.
    Shepherd FA; Evans WK; Feld R; Young V; Patterson GA; Ginsberg R; Johansen E
    J Clin Oncol; 1988 May; 6(5):832-8. PubMed ID: 2835443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment for clinical stage II and III small cell lung cancer patients].
    Kawano R; Tamaki K; Karita S; Yokota T; Ikeda S; Hata E
    Kyobu Geka; 2006 Sep; 59(10):879-83; discussion 883-6. PubMed ID: 16986681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy plus adjuvant surgery for local small cell lung cancer.
    Benfield GF; Matthews HR; Watson DC; Collins FJ; Cullen MH
    Eur J Surg Oncol; 1989 Aug; 15(4):341-4. PubMed ID: 2547664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
    J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study. Leuven Lung Cancer Group.
    Vansteenkiste JF; De Leyn PR; Deneffe GJ; Lievens YN; Nackaerts KL; Van Raemdonck DE; van der Schueren E; Lerut TE; Demedts MG
    Ann Oncol; 1998 Mar; 9(3):261-7. PubMed ID: 9602259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
    Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.